Prostate Cancer Susceptibility Candidate (PRAC) Peptide
PRAC
Reactivité: Mammifères
Hôte: Synthetic
BP, WB, IHC
N° du produit ABIN937516
Aperçu rapide pour Prostate Cancer Susceptibility Candidate (PRAC) Peptide (ABIN937516)
Antigène
PRAC
(Prostate Cancer Susceptibility Candidate (PRAC))
Origine
Mammifères
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Type de proteíne
- Synthetic
-
Séquence
- DQGPAHLTTS KSAFLSNKKT STLKHLLGET RSDGSACNSG ISGGRGRKIP
-
Attributs du produit
-
A synthetic peptide for use as a blocking control in assays to test for specificity of PRAC antibody,
Alternative Names: PRAC control peptide, PRAC antibody Blocking Peptide, Anti-PRAC Blocking Peptide, prostate cancer susceptibility candidate Blocking Peptide, C17orf92 Blocking Peptide, MGC32520 Blocking Peptide
-
-
-
-
Indications d'application
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20 °C long term.
-
-
- PRAC (Prostate Cancer Susceptibility Candidate (PRAC))
-
Sujet
- This gene is reported to be specifically expressed in prostate, rectum and distal colon. Sequence analysis suggests that it may play a regulatory role in the nucleus.
-
Poids moléculaire
- 6 kDa
Antigène
-
Vous êtes ici:
